The Thousand Oaks, Calif.-based biotech pharmaceutical company makes drugs that treat patients in about 100 countries.
Looking for leads, investment insights, or competitive intelligence?
News about Amgen
Amgen says Repatha sold $271 million in the first half of 2018, despite earlier predictions of multi-billion-dollar sales.
Aimovig apparently cuts migraine days significantly.
Novartis and Amgen want to find out with an experimental drug.
The FDA approved the first cancer medicine "biosimilar" Thursday.